[PDF][PDF] Diagnosis, management, and treatment of hepatitis C

DB Strader, T Wright, DL Thomas, LB Seeff - Hepatology, 2004 - Wiley Online Library
Background The hepatitis C virus (HCV) is a major public health problem and a leading
cause of chronic liver disease. In the United States, the Centers for Disease Control and …

American Gastroenterological Association technical review on the management of hepatitis C

JL Dienstag, JG McHutchison - Revista de Gastroenterología de …, 2006 - medigraphic.com
Abreviaturas usadas en este Trabajo: IC: intervalo de confianza; RVT: respuesta virológica
temprana; TAAA: terapia antirretroviral altamente activa; IHA: índice histiológico activo; VIH …

[PDF][PDF] Diagnosis, management, and treatment of hepatitis C: an update

MG Ghany, DB Strader, DL Thomas, LB Seeff - Hepatology, 2009 - Wiley Online Library
Background The hepatitis C virus (HCV) is a major public health problem and a leading
cause of chronic liver disease. 5 An estimated 180 million people are infected worldwide. 6 …

[PDF][PDF] Cost‐effectiveness of hepatitis C virus antiviral treatment for injection drug user populations

NK Martin, P Vickerman, A Miners, GR Foster… - …, 2012 - Wiley Online Library
Injecting drug use is the main risk of hepatitis C virus (HCV) transmission in most developed
countries. HCV antiviral treatment (peginterferon‐α+ ribavirin) has been shown to be cost …

Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups

M Schaefer, F Schmidt, C Folwaczny, R Lorenz… - Hepatology, 2003 - journals.lww.com
Psychiatric disorders or drug addiction are often regarded as contraindications against the
use of interferon alfa (IFN-α) in patients with chronic hepatitis C. Our aim was to obtain …

Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel

V Soriano, M Sulkowski, C Bergin, A Hatzakis… - Aids, 2002 - journals.lww.com
Care of patients with chronic hepatitis C and HIV co-infecti... : AIDS Care of patients with chronic
hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel …

Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users

BR Edlin, TF Kresina, DB Raymond… - Clinical infectious …, 2005 - academic.oup.com
Injection drug use accounts for most of the incident infections with hepatitis C virus (HCV) in
the United States and other developed countries. HCV infection is a complex and …

Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches

GM Asnis, R De La Garza - Journal of clinical gastroenterology, 2006 - journals.lww.com
Hepatitis C viral infection is a global health problem that affects approximately 4 million
people in the United States. Combination treatment with pegylated interferon (IFN)-α plus …

Barriers to the treatment of hepatitis C: patient, provider, and system factors

JA Morrill, M Shrestha, RW Grant - Journal of general internal medicine, 2005 - Springer
Abstract BACKGROUND: Hepatitis C virus (HCV) infection is both prevalent and
undertreated. OBJECTIVE: To identify barriers to HCV treatment in primary care practice …

Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study)

B Fischer, J Rehm, S Brissette, S Brochu… - Journal of Urban …, 2005 - Springer
Most of the estimated 125,000 injection drug users (IDUs) in Canada use illicit opioids and
are outside treatment (ie, methadone maintenance treatment). Empirical data suggest that …